Faculty

Institution

Unit

Venue

Juan Gallegos

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

NoneJuan Gallegos is currently serving as a Hematopoietic Biology And Malignancy faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Juan Gallegos

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology immunology genomics cancer research genome biology genetics medicine pharmacology cancer care molecular cancer cancer cells immune checkpoint inhibitors exceptional response human genetics hematology nephrology cancer immunotherapy immunotherapy experimental medicine medical mycology medicinal research cellular therapy molecular metabolism cell metabolism biomedical informatics molecular informatics histopathology oncogenes cancer genetics cancer genomics hematological malignancies molecular regulation cell regulation transcription regulation gene regulation cancer immunosurveillance anti-cancer agents cancer treatment genitourinary cancers secondary metabolism long-read sequencing next-generation sequencing high throughput sequencing computational genomics liver cancer biliary cancer genome architecture chromatin landscape transcriptional dependencies chronic lymphocytic leukemia metabolic determinants renal cell carcinoma technical artifacts abstract 1495 intrahepatic cholangiocarcinoma abstract 3075

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 1495: A Novel, Deep Learning -Based Filtering Tool for Enhanced Detection of Technical Artifacts in Whole-Genome Sequencing Data. Cancer Research (2026)

genomicsgenome biologylong-read sequencingbiomedical informaticsnext-generation sequencinghigh throughput sequencingtechnical artifactssystems biologyabstract 1495deep learningcomputational genomicsdata sciencemolecular informaticsbioinformatics

Abstract 3075: Fgfr2b is a Highly Prevalent and Actionable Cell Surface Target in Intrahepatic Cholangiocarcinoma. Cancer Research (2026)

intrahepatic cholangiocarcinomaliver cancermolecular cancerbiliary cancerhistopathologyabstract 3075oncologyhepatologycancer cellsoncogenespathologytumor biologycell biology

Metabolic Determinants of Exceptional Response to Immune Checkpoint Inhibition in Renal Cell Carcinoma.. Journal of Clinical Oncology (2025)

Renee Maria SalibyChris LabakiTejas JammihalHanna SoulatiJuan GallegosArnau PerisDustin Barrett McCurryValisha ShahDeepak PoduvalTalal El ZarifNourhan El AhmarYasmin Nabil LaimonAseman Bagheri SheshdehMarc EidKatherine KrajewskiSabina SignorettiEliezer Van AllenSachet A ShuklaToni K. ChoueiriDavid A. Braun

immunologyexceptional responsepharmacologysecondary metabolismsystems biologyimmune checkpoint inhibitorsmetabolic determinantsmolecular metabolismoncologykidney cancerimmune responsesmetabolismtumor biologyrenal cell carcinomacell metabolism

1891P Determinants of Exceptional Response to Immune Checkpoint Inhibition in Metastatic Clear Cell Renal Cell Carcinoma. Annals of Oncology (2023)

R.M. SalibyT. JammihalC. LabakiH. SoulatiJ. GallegosA. PerisD. McCurryC. YuV. ShahD. PoduvalT. El ZarifN. El AhmarY.N. LaimonD.Y.C. HengS. SignorettiE.M. Van AllenT.K. ChoueiriS. ShuklaD.A. Braun

medicinecancer carecancer immunosurveillanceanti-cancer agentscancer researchnephrologyimmune checkpoint inhibitorscancer immunotherapycancer treatmentimmunotherapyexceptional responseimmunologymedical mycologypharmacologygenitourinary cancersoncologymedicinal researchcancer cellscellular therapy

Hdac1 Regulates the Chromatin Landscape to Control Transcriptional Dependencies in Chronic Lymphocytic Leukemia. Blood Advances (2022)

Tzung-Huei LaiHatice Gulcin OzerPierluigi GaspariniGiovanni NigitaRosario DistefanoLianbo YuJanani RavikrishnanSelen YilmazJuan GallegosSachet ShuklaVinay PuduvalliJennifer WoyachRosa LapalombellaJames BlachlyJohn C. ByrdDeepa Sampath

hematological malignancieschromatin landscapemolecular regulationhuman geneticsgenome biologymedicinecancer carehematologymolecular cancertranscriptional dependenciescancer researchchronic lymphocytic leukemiacell regulationimmunologygenomicstranscription regulationgeneticsoncologyexperimental medicinegene regulation

Genome Architecture Marked by Retrotransposons Modulates Predisposition to Dna Methylation in Cancer. Genome Research (2010)

Marcos R.H. EstécioJuan GallegosCéline VallotRyan J. CastoroWoonbok ChungShinji MaegawaYasuhiro OkiYutaka KondoJaroslav JelinekLanlan ShenHelge HartungPeter D. AplanBogdan A. CzerniakShoudan LiangJean-Pierre J. Issa

genomicsgenome biologycancer geneticsgenome architecturecancer researchgeneticscancer genomics

1
10 / page

Juan Gallegos

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

NoneJuan Gallegos is currently serving as a Hematopoietic Biology And Malignancy faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Juan Gallegos

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 1495: A Novel, Deep Learning -Based Filtering Tool for Enhanced Detection of Technical Artifacts in Whole-Genome Sequencing Data. Cancer Research (2026)

Abstract 3075: Fgfr2b is a Highly Prevalent and Actionable Cell Surface Target in Intrahepatic Cholangiocarcinoma. Cancer Research (2026)

intrahepatic cholangiocarcinomaliver cancermolecular cancerbiliary cancerhistopathologyabstract 3075oncologyhepatologycancer cellsoncogenespathologytumor biologycell biology

Metabolic Determinants of Exceptional Response to Immune Checkpoint Inhibition in Renal Cell Carcinoma.. Journal of Clinical Oncology (2025)

1891P Determinants of Exceptional Response to Immune Checkpoint Inhibition in Metastatic Clear Cell Renal Cell Carcinoma. Annals of Oncology (2023)

R.M. SalibyT. JammihalC. LabakiH. SoulatiJ. GallegosA. PerisD. McCurryC. YuV. ShahD. PoduvalT. El ZarifN. El AhmarY.N. LaimonD.Y.C. HengS. SignorettiE.M. Van AllenT.K. ChoueiriS. ShuklaD.A. Braun

Hdac1 Regulates the Chromatin Landscape to Control Transcriptional Dependencies in Chronic Lymphocytic Leukemia. Blood Advances (2022)

Genome Architecture Marked by Retrotransposons Modulates Predisposition to Dna Methylation in Cancer. Genome Research (2010)

genomicsgenome biologycancer geneticsgenome architecturecancer researchgeneticscancer genomics

1
10 / page